-
Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages
Source: Buzz FX / 14 Jan 2025 04:56:16 America/New_York
Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has been assign
Read more...